
    
      The primary objectives of this clinical trial are:

        1. To train potential Phase 3 investigational sites in the preparation and andministration
           of PB127

        2. To train potential Phase 3 investigational sites in the acquisition of adequate images

        3. To collect additional safety information regarding intravenous administration of PB127

        4. To obtain a larger sample of images obtained with the Acuson Sequoia ultrasound system.
    
  